524 related articles for article (PubMed ID: 29483774)
21. Use of clinical characteristics to predict spirometric classification of obstructive lung disease.
Pascoe SJ; Wu W; Collison KA; Nelsen LM; Wurst KE; Lee LA
Int J Chron Obstruct Pulmon Dis; 2018; 13():889-902. PubMed ID: 29559773
[TBL] [Abstract][Full Text] [Related]
22. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters.
Zou Y; Chen X; Liu J; Zhou DB; Kuang X; Xiao J; Yu Q; Lu X; Li W; Xie B; Chen Q
Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868
[TBL] [Abstract][Full Text] [Related]
23. Decreased serum club cell secretory protein in asthma and chronic obstructive pulmonary disease overlap: a pilot study.
Oh JY; Lee YS; Min KH; Hur GY; Lee SY; Kang KH; Rhee CK; Park SJ; Shim JJ
Int J Chron Obstruct Pulmon Dis; 2018; 13():3411-3417. PubMed ID: 30425470
[TBL] [Abstract][Full Text] [Related]
24. Identification of Asthma-COPD Overlap, Asthma, and Chronic Obstructive Pulmonary Disease Phenotypes in Patients with Airway Obstruction: Influence on Treatment Approach.
Romem A; Rokach A; Bohadana A; Babai P; Arish N; Azulai H; Glazer M; Izbicki G
Respiration; 2020; 99(1):35-42. PubMed ID: 31694032
[TBL] [Abstract][Full Text] [Related]
25. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
Calle Rubio M; Casamor R; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the Characteristics of Asthma in Severe and Extremely Severe COPD.
Chen FJ; Lin GP; Huang XY; Liu YL; Zeng ZM; Guo YB
Int J Chron Obstruct Pulmon Dis; 2019; 14():2663-2671. PubMed ID: 31819399
[TBL] [Abstract][Full Text] [Related]
27. Eosinophilic and Neutrophilic Airway Inflammation in the Phenotyping of Mild-to-Moderate Asthma and Chronic Obstructive Pulmonary Disease.
Górska K; Paplińska-Goryca M; Nejman-Gryz P; Goryca K; Krenke R
COPD; 2017 Apr; 14(2):181-189. PubMed ID: 27983888
[TBL] [Abstract][Full Text] [Related]
28. Comparison of serum biomarkers between patients with asthma and with chronic obstructive pulmonary disease.
Han SS; Lee WH; Hong Y; Kim WJ; Yang J; Lim MN; Lee SJ; Kwon JW
J Asthma; 2016 Aug; 53(6):583-8. PubMed ID: 27104648
[TBL] [Abstract][Full Text] [Related]
29. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
[TBL] [Abstract][Full Text] [Related]
30. Analysis of Blood Biomarkers in Patients with Chronic Obstructive Pulmonary Disease (COPD) and with Asthma-COPD Overlap (ACO).
Gava G; Núñez A; Esquinas C; Sarasate M; Loeb E; Pirina P; Miravitlles M; Barrecheguren M
COPD; 2020 Jun; 17(3):306-310. PubMed ID: 32380914
[TBL] [Abstract][Full Text] [Related]
31. Metabolomic fingerprinting and systemic inflammatory profiling of asthma COPD overlap (ACO).
Ghosh N; Choudhury P; Kaushik SR; Arya R; Nanda R; Bhattacharyya P; Roychowdhury S; Banerjee R; Chaudhury K
Respir Res; 2020 May; 21(1):126. PubMed ID: 32448302
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.
de Moraes MR; da Costa AC; Corrêa Kde S; Junqueira-Kipnis AP; Rabahi MF
Int J Chron Obstruct Pulmon Dis; 2014; 9():735-43. PubMed ID: 25114519
[TBL] [Abstract][Full Text] [Related]
33. Comparison of inflammation biomarkers among chronic obstructive pulmonary disease groups: A cross sectional study.
Yazici O; Gulen ST; Yenisey C; Eryilmaz U; Abas BI; Polatli M
Niger J Clin Pract; 2020 Jun; 23(6):817-824. PubMed ID: 32525117
[TBL] [Abstract][Full Text] [Related]
34. Differences in systemic inflammation between cigarette and biomass smoke-induced COPD.
Golpe R; Martín-Robles I; Sanjuán-López P; Pérez-de-Llano L; González-Juanatey C; López-Campos JL; Arellano-Orden E
Int J Chron Obstruct Pulmon Dis; 2017; 12():2639-2646. PubMed ID: 28979110
[TBL] [Abstract][Full Text] [Related]
35. Systemic and Tumor Th1 and Th2 Inflammatory Profile and Macrophages in Lung Cancer: Influence of Underlying Chronic Respiratory Disease.
Mateu-Jimenez M; Curull V; Pijuan L; Sánchez-Font A; Rivera-Ramos H; Rodríguez-Fuster A; Aguiló R; Gea J; Barreiro E
J Thorac Oncol; 2017 Feb; 12(2):235-248. PubMed ID: 27793775
[TBL] [Abstract][Full Text] [Related]
36. Altered serum levels of type I collagen turnover indicators accompanied by IL-6 and IL-8 release in stable COPD.
Zeng YY; Hu WP; Zuo YH; Wang XR; Zhang J
Int J Chron Obstruct Pulmon Dis; 2019; 14():163-168. PubMed ID: 30655663
[TBL] [Abstract][Full Text] [Related]
37. Biomarkers for differentiation of patients with asthma and chronic obstructive pulmonary disease.
Katoh S; Ikeda M; Shirai R; Abe M; Ohue Y; Kobashi Y; Oka M
J Asthma; 2018 Oct; 55(10):1052-1058. PubMed ID: 29035604
[TBL] [Abstract][Full Text] [Related]
38. Th-2 signature in chronic airway diseases: towards the extinction of asthma-COPD overlap syndrome?
Cosío BG; Pérez de Llano L; Lopez Viña A; Torrego A; Lopez-Campos JL; Soriano JB; Martinez Moragon E; Izquierdo JL; Bobolea I; Callejas J; Plaza V; Miravitlles M; Soler-Catalunya JJ;
Eur Respir J; 2017 May; 49(5):. PubMed ID: 28461299
[TBL] [Abstract][Full Text] [Related]
39. Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.
Wu Y; Shen Y; Zhang J; Wan C; Wang T; Xu D; Yang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2015; 10():2405-12. PubMed ID: 26609227
[TBL] [Abstract][Full Text] [Related]
40. Systemic inflammation in patients with COPD and pulmonary hypertension.
Joppa P; Petrasova D; Stancak B; Tkacova R
Chest; 2006 Aug; 130(2):326-33. PubMed ID: 16899829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]